114 related articles for article (PubMed ID: 38279420)
21. Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
Huang W; Xing Y; Zhu L; Zhuo J; Cai M
Exp Cell Res; 2021 Sep; 406(1):112633. PubMed ID: 34089726
[TBL] [Abstract][Full Text] [Related]
22. The natural medicinal fungus Huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death.
Zhang Z; Shen C; Zhou F
Med Oncol; 2022 Sep; 39(12):221. PubMed ID: 36175804
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-Triggered Delivery of Iproplatin from Microbubble-Conjugated Liposomes.
Browning R; Thomas N; Marsh LK; Tear LR; Owen J; Stride E; Farrer NJ
ChemistryOpen; 2021 Dec; 10(12):1170-1176. PubMed ID: 34708552
[TBL] [Abstract][Full Text] [Related]
24. In Vitro and In Vivo Evaluation of Targeted Sunitinib-Loaded Polymer Microbubbles Against Proliferation of Renal Cell Carcinoma.
Hu J; Zong Y; Li J; Zhou X; Zhang J; Zhu T; Jiao M; Su H; Bo B
J Ultrasound Med; 2016 Mar; 35(3):589-97. PubMed ID: 26921089
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer.
Ji Y; Han Z; Shao L; Zhao Y
Cancer Med; 2016 Sep; 5(9):2534-43. PubMed ID: 27465833
[TBL] [Abstract][Full Text] [Related]
26. Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System.
Liufu C; Li Y; Tu J; Zhang H; Yu J; Wang Y; Huang P; Chen Z
Int J Nanomedicine; 2019; 14():8923-8941. PubMed ID: 31814720
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy.
Lu W; Liu W; Hu A; Shen J; Yi H; Cheng Z
Int J Nanomedicine; 2023; 18():861-879. PubMed ID: 36844433
[TBL] [Abstract][Full Text] [Related]
29. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
Tinkov S; Winter G; Coester C; Bekeredjian R
J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
[TBL] [Abstract][Full Text] [Related]
30. Removal of ligand-bound liposomes from cell surfaces by microbubbles exposed to ultrasound.
Ibsen S; Mora R; Shi G; Schutt C; Cui W; Benchimol M; Serra V; Esener S
J Biol Phys; 2017 Dec; 43(4):493-510. PubMed ID: 29124623
[TBL] [Abstract][Full Text] [Related]
31. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
[TBL] [Abstract][Full Text] [Related]
32. In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.
Zhang H; Ingham ES; Gagnon MK; Mahakian LM; Liu J; Foiret JL; Willmann JK; Ferrara KW
Biomaterials; 2017 Feb; 118():63-73. PubMed ID: 27940383
[TBL] [Abstract][Full Text] [Related]
33. Small interfering RNA targeting alpha7 nicotinic acetylcholine receptor sensitizes hepatocellular carcinoma cells to sorafenib.
Hajiasgharzadeh K; Somi MH; Mansoori B; Khaze Shahgoli V; Derakhshani A; Mokhtarzadeh A; Shanehbandi D; Baradaran B
Life Sci; 2020 Mar; 244():117332. PubMed ID: 31962133
[TBL] [Abstract][Full Text] [Related]
34. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery.
Ferrara KW; Borden MA; Zhang H
Acc Chem Res; 2009 Jul; 42(7):881-92. PubMed ID: 19552457
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
36. Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells.
Caputo TM; Cusano AM; Principe S; Cicatiello P; Celetti G; Aliberti A; Micco A; Ruvo M; Tagliamonte M; Ragone C; Minopoli M; Carriero MV; Buonaguro L; Cusano A
Int J Nanomedicine; 2023; 18():4121-4142. PubMed ID: 37525693
[TBL] [Abstract][Full Text] [Related]
37. Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid.
Yurdacan B; Egeli U; Guney Eskiler G; Eryilmaz IE; Cecener G; Tunca B
J Pharm Pharmacol; 2019 Jul; 71(7):1119-1132. PubMed ID: 31025377
[TBL] [Abstract][Full Text] [Related]
38. Dual-functionalized nanoparticles loaded microbubbles for enhancement of drug uptake.
Li Y; Zhang X; Luo W; Wang D; Yang L; Wang J; Zhang L; Zhang S; Luo S; Wang Y
Ultrasonics; 2018 Jul; 87():82-90. PubMed ID: 29475016
[TBL] [Abstract][Full Text] [Related]
39. The antitumor effect of a new docetaxel-loaded microbubble combined with low-frequency ultrasound in vitro: preparation and parameter analysis.
Ren ST; Liao YR; Kang XN; Li YP; Zhang H; Ai H; Sun Q; Jing J; Zhao XH; Tan LF; Shen XL; Wang B
Pharm Res; 2013 Jun; 30(6):1574-85. PubMed ID: 23417512
[TBL] [Abstract][Full Text] [Related]
40. Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance).
Tran NH; Foster NR; Mahipal A; Byrne T; Hubbard J; Silva A; Mody K; Alberts S; Borad MJ
Invest New Drugs; 2021 Aug; 39(4):1072-1080. PubMed ID: 33646489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
